DiscoverLung Cancer ConsideredIASLC Lung Cancer Considered: ESMO Asia 2024 Highlights
IASLC Lung Cancer Considered: ESMO Asia 2024 Highlights

IASLC Lung Cancer Considered: ESMO Asia 2024 Highlights

Update: 2024-12-16
Share

Description

Lung Cancer Considered host Dr. Stephen Liu and two distinguished thoracic oncologists review the highlights from the recently completed ESMO Asia 2024 meeting, held in Singapore. The episode covers a number of trials, including an update on FLAURA2, TROPION-Lung01 and TROPION-Lung05, ALESIA, and PACIFIC 5.

Guest: Dr. Misako Nagasaka, Associate Professor from the University of California, Irvine

Guest: by Dr. Molly Li, Clinical Assistant Professor from Chinese University of Hong Kong.
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

IASLC Lung Cancer Considered: ESMO Asia 2024 Highlights

IASLC Lung Cancer Considered: ESMO Asia 2024 Highlights

IASLC